From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.
Here you can find a list of upcoming health and scientific conferences, both hosted by ASHM and those of our sector partners and supporters.
These flagship conferences cover topics including sexual and reproductive health, HIV, BBVs, COVID, mpox and other transmissible infections.
